This content is machine translated Non-resectable melanoma New triple therapy improves progression-free survival Both protein kinase inhibitors and ipilimumab/nivolumab combined have better efficacy than their respective monotherapies in patients with non-resectable melanoma. This has been known for some time. An interesting new approach…
View Post 10 min This content is machine translated Cardio-Oncology Challenges of new cancer therapies Innovative therapies have improved the prognosis of many oncological diseases. A major limitation for the individual prognosis are disease- and therapy-associated cardiovascular complications. Even rare events can have serious consequences.
